A non-opioid drug for pain developed by UK biotech Levicept, with a new mechanism of action, has shown it can reduce pain associated with osteoarthritis in a phase 2 trial. Neurotrophin-3 (NT-3 ...

Emotion regulation and pain catastrophizing influenced pain severity and interference in patients taking opioid medications for chronic noncancer pain.

“We are working with urgency to file the new drug application for VX-548 and bring this non-opioid medicine to the millions of patients who suffer from acute pain each year in the US,” he adde ...

Discover why Vertex stock is undervalued with the potential of VX-548 as a groundbreaking pain treatment drug in the ...

Yet poppy seeds aren’t the only thing that can skew a rapid drug test. “There’s a wide range of things that can cause false ...

Keep in mind that alcohol and drugs with acetaminophen don't mix. The combination can raise your risk of severe liver damage. Narcotics: Narcotic pain relievers work on pain receptors in the brain ...

We are calling on Missouri’s congressional delegation to take action on the “Alternatives to Pain Act ... coverage for new non-opiate pain management medications. As the Vice President ...

The Global non-opioid pain relief device market, which was valued at US$ 5,444.8 million in 2023, is expected to reach US$ 11,440.6 million by 2032, signaling a significant growth trajectory at a CAGR ...

At the same time, the massive overconsumption of pain-management opioid drugs, which can be addictive, continues to shatter lives. Nature Outlook: Pain Improving the treatment of pain requires a ...

A meta-analysis reveals triptans as the most effective acute migraine treatments, highlighting the need for their inclusion ...